Since going public in 2021 through a $1.6 billion SPAC deal, its grown into a major telehealth company, expanding into mental health and dermatology although Hims continues to post videos about, well: On May 20, Hims announced it would also sell its own version of GLP-1 weight loss injections like Ozempic and Wegovy
If you are obese with a Body Mass Index (BMI) of over 30 or overweight with a BMI of 27 and above and have other risk factors, you could be the right candidate for this weight loss therapy
2035 Mapping Treatment-Induced Adverse Events against HRQoL Questionnaires in Non-Small Cell Lung Cancer: Evaluation of the EORTC QLQ-C30 and QLQ-LC29 Lotte Van der Weijst 1 , Cecilia Pompili 2,3 , Maria Teixeira 4 , Hayat Hamzeh 5 , Claire Piccinin 4 , Madeline Pe 4 1 EORTC, Brussels, Belgium, 2 Institute for Clinical & Applied Health Research, University of Hull, UK, 3 Section of Patient Centred Outcomes Research, University of Leeds, UK, 4 Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium, 5 Leeds Institute of Medical Research, University of Leeds, UK Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :2035 Aims This study aims to evaluate the relevance of health-related quality of life (HRQoL) questionnaires in capturing treatment-induced adverse events
11 of the Best Foods High in Magnesium Heres a list of some of the foods most abundant in magnesium to get you started
Umbrella Labs Retatrutide Peptide Research Use Only Program Supports High Rigor Multi Receptor Endocrine Signaling, Metabolic Pathway Mapping, And Reproducible Bench Workflows TUCSON, AZ / ACCESS Newswire / February 9, 2026 / Umbrella Labs today announced an expanded research focused program for retatrutide peptide to support laboratories running multi receptor signaling studies, pathway mapping experiments, and reproducibility forward assay development under controlled bench conditions
95 Lixisenatide is a short-acting GLP-1RA agent, 96,97 and once-daily lixisenatide can improve patient compliance to a certain extent and reduce the occurrence of hypoglycemia
